康宁杰瑞制药-B授出5万份购股权及49万股奖励股份

格隆汇资讯
23 Apr

格隆汇4月23日丨康宁杰瑞制药-B(09966.HK)公告,于2025年4月23日,根据首次公开发售后购股权计划,公司已决议向两名合资格参与者("购股权承授人")(即集团的雇员)授出购股权,以认购最多合共5万股公司股本中每股面值0.000002美元公司普通股,惟须待购股权承授人接纳后,方可作实。根据限制性股份奖励计划,公司已决议向五名合资格参与者("奖励承授人")(即集团的雇员)授出合共49万股...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10